This is a failure of study design. would have been nice if they had appropriate inclusion criteria
- Forums
- ASX - By Stock
- DXB
- Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-10
-
- There are more pages in this discussion • 618 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
57.0¢ |
Change
-0.045(7.32%) |
Mkt cap ! $313.3M |
Open | High | Low | Value | Volume |
62.0¢ | 65.0¢ | 56.5¢ | $3.477M | 5.806M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 141059 | 56.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 24687 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15517 | 0.580 |
1 | 303 | 0.575 |
9 | 96062 | 0.570 |
3 | 48987 | 0.565 |
8 | 207265 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.560 | 49307 | 2 |
0.565 | 2320 | 2 |
0.570 | 29256 | 4 |
0.575 | 29584 | 2 |
0.580 | 1666 | 1 |
Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online